{"id":80430,"date":"2026-05-28T16:08:05","date_gmt":"2026-05-28T10:38:05","guid":{"rendered":"https:\/\/matribhumisamachar.com\/en\/?p=80430"},"modified":"2026-05-28T16:08:05","modified_gmt":"2026-05-28T10:38:05","slug":"zydus-lifesciences-raises-buyback-price-to-%e2%82%b91260-per-share-trims-total-share-count","status":"publish","type":"post","link":"https:\/\/matribhumisamachar.com\/en\/2026\/05\/28\/zydus-lifesciences-raises-buyback-price-to-%e2%82%b91260-per-share-trims-total-share-count\/","title":{"rendered":"Zydus Lifesciences Raises Buyback Price to \u20b91260 Per Share, Trims Total Share Count"},"content":{"rendered":"<div id=\"model-response-message-contentr_41240cb38daa5d3d\" class=\"markdown markdown-main-panel enable-updated-hr-color\" dir=\"ltr\" aria-live=\"polite\" aria-busy=\"false\">\n<p data-path-to-node=\"8\"><strong>Mumbai. Thursday, 28 May 2026<\/strong><\/p>\n<p style=\"text-align: justify;\" data-path-to-node=\"8\">Indian pharmaceutical major <b data-path-to-node=\"8\" data-index-in-node=\"28\">Zydus Lifesciences<\/b> has announced a crucial tactical modification to its ongoing share buyback program. Acting on the recommendations of its authorized buyback committee, the company has officially approved a significant increase in the buyback price, offering to repurchase shares from eligible investors at <b data-path-to-node=\"8\" data-index-in-node=\"336\">\u20b91,260 per share<\/b>.<\/p>\n<p style=\"text-align: justify;\" data-path-to-node=\"9\">While this adjustment brings excellent news for shareholders tracking premium exit valuations, it simultaneously shifts the math regarding acceptance probabilities.<\/p>\n<h2 style=\"text-align: justify;\" data-path-to-node=\"11\">Higher Premium, Calibrated Share Volumetrics<\/h2>\n<p style=\"text-align: justify;\" data-path-to-node=\"12\">While the buyback price has been upwardly revised from its previous framework, Zydus Lifesciences has concurrently downsized the total volume of equity shares it intends to absorb.<\/p>\n<ul style=\"text-align: justify;\" data-path-to-node=\"13\">\n<li>\n<p data-path-to-node=\"13,0,0\"><b data-path-to-node=\"13,0,0\" data-index-in-node=\"0\">Previous target:<\/b> The company initially planned to buy back roughly 95.65 lakh shares.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"13,1,0\"><b data-path-to-node=\"13,1,0\" data-index-in-node=\"0\">Revised target:<\/b> The updated regulatory plan caps the target at <b data-path-to-node=\"13,1,0\" data-index-in-node=\"63\">87.30 lakh shares<\/b>.<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" data-path-to-node=\"14\">According to exchange filings released by the drugmaker, this revised equity chunk represents approximately 90.87% of the total paid-up share capital originally earmarked under the primary buyback proposal.<\/p>\n<p style=\"text-align: justify;\" data-path-to-node=\"15\">Crucially, despite reducing the volumetric share count, the overall capital footprint of the program remains completely unaffected. Zydus Lifesciences will continue ahead with its <b data-path-to-node=\"15\" data-index-in-node=\"180\">\u20b91,100 crore budget<\/b> distributed via the strict <b data-path-to-node=\"15\" data-index-in-node=\"227\">Tender Offer Route<\/b>. Consequently, public investors receive a significantly higher financial compensation per unit asset, even though a smaller absolute number of shares will be admitted into the final payout scheme.<\/p>\n<h2 style=\"text-align: justify;\" data-path-to-node=\"17\">Strategic Mechanics: Why Did Management Pivot?<\/h2>\n<p style=\"text-align: justify;\" data-path-to-node=\"18\">In corporate finance, when an enterprise&#8217;s market equity value rallies close to or surpasses an early proposed buyback price, the financial incentive for investors to tender their allocations evaporates.<\/p>\n<p style=\"text-align: justify;\" data-path-to-node=\"19\">Following a stellar Q4 earnings season\u2014where Zydus reported a strong 9% year-on-year growth in consolidated net profit to \u20b91,272.5 crore\u2014the open-market stock price climbed steadily. To counter this and maintain a healthy, enticing premium over the prevailing market rate, the board adjusted the pricing upward to \u20b91,260. Furthermore, the company explicitly confirmed that <b data-path-to-node=\"19\" data-index-in-node=\"373\">promoter and promoter group entities will participate<\/b>, ensuring the optimization of its overall equity structure.<\/p>\n<h2 style=\"text-align: justify;\" data-path-to-node=\"21\">Core Financial Metrics: Original vs. Revised Buyback<\/h2>\n<p style=\"text-align: justify;\" data-path-to-node=\"22\">To help visual-minded investors grasp the exact fiscal realignment, the underlying structural differences are broken down below:<\/p>\n<table data-path-to-node=\"23\">\n<thead>\n<tr>\n<td><strong>Structural Parameter<\/strong><\/td>\n<td><strong>Original Specifications<\/strong><\/td>\n<td><strong>Revised Specifications<\/strong><\/td>\n<td><strong>Net Realized Change<\/strong><\/td>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><span data-path-to-node=\"23,1,0,0\"><b data-path-to-node=\"23,1,0,0\" data-index-in-node=\"0\">Buyback Price (Per Share)<\/b><\/span><\/td>\n<td><span data-path-to-node=\"23,1,1,0\">\u20b91,150<\/span><\/td>\n<td><span data-path-to-node=\"23,1,2,0\"><b data-path-to-node=\"23,1,2,0\" data-index-in-node=\"0\">\u20b91,260<\/b><\/span><\/td>\n<td><span data-path-to-node=\"23,1,3,0\">+9.56% Elevation<\/span><\/td>\n<\/tr>\n<tr>\n<td><span data-path-to-node=\"23,2,0,0\"><b data-path-to-node=\"23,2,0,0\" data-index-in-node=\"0\">Maximum Repurchase Volume<\/b><\/span><\/td>\n<td><span data-path-to-node=\"23,2,1,0\">~95.65 Lakh Shares<\/span><\/td>\n<td><span data-path-to-node=\"23,2,2,0\"><b data-path-to-node=\"23,2,2,0\" data-index-in-node=\"0\">~87.30 Lakh Shares<\/b><\/span><\/td>\n<td><span data-path-to-node=\"23,2,3,0\">-8.73% Reduction<\/span><\/td>\n<\/tr>\n<tr>\n<td><span data-path-to-node=\"23,3,0,0\"><b data-path-to-node=\"23,3,0,0\" data-index-in-node=\"0\">Absolute Capital Outlay<\/b><\/span><\/td>\n<td><span data-path-to-node=\"23,3,1,0\">\u20b91,100 Crore<\/span><\/td>\n<td><span data-path-to-node=\"23,3,2,0\"><b data-path-to-node=\"23,3,2,0\" data-index-in-node=\"0\">\u20b91,100 Crore<\/b><\/span><\/td>\n<td><span data-path-to-node=\"23,3,3,0\"><i data-path-to-node=\"23,3,3,0\" data-index-in-node=\"0\">No Change<\/i><\/span><\/td>\n<\/tr>\n<tr>\n<td><span data-path-to-node=\"23,4,0,0\"><b data-path-to-node=\"23,4,0,0\" data-index-in-node=\"0\">Percentage of Paid-up Capital<\/b><\/span><\/td>\n<td><span data-path-to-node=\"23,4,1,0\">0.95%<\/span><\/td>\n<td><span data-path-to-node=\"23,4,2,0\"><b data-path-to-node=\"23,4,2,0\" data-index-in-node=\"0\">0.87%<\/b><\/span><\/td>\n<td><span data-path-to-node=\"23,4,3,0\">Strategic Compression<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 style=\"text-align: justify;\" data-path-to-node=\"25\">Important Timeline Adjustments &amp; Eligibility for Investors<\/h2>\n<p style=\"text-align: justify;\" data-path-to-node=\"26\">The critical data parameters that public market investors need to keep in mind regarding execution timelines include:<\/p>\n<ul style=\"text-align: justify;\" data-path-to-node=\"27\">\n<li>\n<p data-path-to-node=\"27,0,0\"><b data-path-to-node=\"27,0,0\" data-index-in-node=\"0\">The Functional Record Date:<\/b> The company has firmly set <b data-path-to-node=\"27,0,0\" data-index-in-node=\"55\">Friday, May 29, 2026<\/b>, as the official Record Date. This determines which specific depository accounts hold valid equity tracking codes entitled to participate in the \u20b91,260 payout scheme.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"27,1,0\"><b data-path-to-node=\"27,1,0\" data-index-in-node=\"0\">The T+1 Settlement Constraint:<\/b> Because Indian capital markets operate on a rigid T+1 rolling settlement timeline, and Thursday, May 28, 2026, observed a market holiday for Bakri Id, the final valid window to purchase shares on the open exchange to claim buyback eligibility was <b data-path-to-node=\"27,1,0\" data-index-in-node=\"278\">Wednesday, May 27, 2026<\/b>.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"27,2,0\"><b data-path-to-node=\"27,2,0\" data-index-in-node=\"0\">Compression of the Acceptance Ratio:<\/b> Because the total volume of shares being pulled out of the ecosystem has dropped from 95.65 lakh to 87.30 lakh, the overall acceptance ratio will naturally face downward pressure. Investors should carefully calculate their prospective allocations when the formal Letter of Offer is dispatched.<\/p>\n<\/li>\n<\/ul>\n<h3 style=\"text-align: justify;\" data-path-to-node=\"29\">External Navigation &amp; Multi-Language Portals<\/h3>\n<p style=\"text-align: justify;\" data-path-to-node=\"30\">For readers looking for verified grassroots news, regional insights, and ongoing stock market developments across India, explore the following verified official networks:<\/p>\n<ul data-path-to-node=\"31\">\n<li style=\"text-align: justify;\">\n<p data-path-to-node=\"31,0,0\"><b data-path-to-node=\"31,0,0\" data-index-in-node=\"0\">Global Perspectives &amp; Institutional News:<\/b> Visit the main English division via the <a class=\"ng-star-inserted\" href=\"https:\/\/matribhumisamachar.com\/en\/\" target=\"_blank\" rel=\"noopener\" data-hveid=\"0\" data-ved=\"0CAAQ_4QMahgKEwiY1vbV1duUAxUAAAAAHQAAAAAQ4AE\">Matribhumi Samachar English Home Page<\/a>.<\/p>\n<\/li>\n<li style=\"text-align: justify;\">\n<p data-path-to-node=\"31,1,0\"><b data-path-to-node=\"31,1,0\" data-index-in-node=\"0\">National Updates:<\/b> Stay informed on public policy, governance, and macroeconomic shifts at the <a class=\"ng-star-inserted\" href=\"https:\/\/matribhumisamachar.com\/en\/category\/national\/\" target=\"_blank\" rel=\"noopener\" data-hveid=\"0\" data-ved=\"0CAAQ_4QMahgKEwiY1vbV1duUAxUAAAAAHQAAAAAQ4QE\">Matribhumi Samachar National Category Hub<\/a>.<\/p>\n<\/li>\n<\/ul>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Mumbai. Thursday, 28 May 2026 Indian pharmaceutical major Zydus Lifesciences has announced a crucial tactical modification to its ongoing share buyback program. Acting on the recommendations of its authorized buyback committee, the company has officially approved a significant increase in the buyback price, offering to repurchase shares from eligible investors at \u20b91,260 per share. While &hellip;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[34274,34272,34275,34273,34271,34270],"class_list":["post-80430","post","type-post","status-publish","format-standard","","category-business-english-news","tag-capital-allocation-strategy","tag-indian-pharma-stocks-news","tag-sebi-retail-reservation-quota","tag-share-buyback-record-date","tag-zydus-buyback-revised-price","tag-zydus-lifesciences-share-buyback-2026"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.8.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Zydus Lifesciences Raises Buyback Price to \u20b91260 Per Share, Trims Total Share Count - Matribhumi Samachar English<\/title>\n<meta name=\"description\" content=\"Zydus Lifesciences revises its ongoing share buyback program, raising the price to \u20b91260 per share while cutting the share count to 87.30 lakh shares. Discover the impact on investors, settlement cycles, and acceptance ratios.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/matribhumisamachar.com\/en\/2026\/05\/28\/zydus-lifesciences-raises-buyback-price-to-\u20b91260-per-share-trims-total-share-count\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Zydus Lifesciences Raises Buyback Price to \u20b91260 Per Share, Trims Total Share Count - Matribhumi Samachar English\" \/>\n<meta property=\"og:description\" content=\"Zydus Lifesciences revises its ongoing share buyback program, raising the price to \u20b91260 per share while cutting the share count to 87.30 lakh shares. Discover the impact on investors, settlement cycles, and acceptance ratios.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/matribhumisamachar.com\/en\/2026\/05\/28\/zydus-lifesciences-raises-buyback-price-to-\u20b91260-per-share-trims-total-share-count\/\" \/>\n<meta property=\"og:site_name\" content=\"Matribhumi Samachar English\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-28T10:38:05+00:00\" \/>\n<meta name=\"author\" content=\"Saransh Kanaujia\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Saransh Kanaujia\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/matribhumisamachar.com\/en\/2026\/05\/28\/zydus-lifesciences-raises-buyback-price-to-%e2%82%b91260-per-share-trims-total-share-count\/\",\"url\":\"https:\/\/matribhumisamachar.com\/en\/2026\/05\/28\/zydus-lifesciences-raises-buyback-price-to-%e2%82%b91260-per-share-trims-total-share-count\/\",\"name\":\"Zydus Lifesciences Raises Buyback Price to \u20b91260 Per Share, Trims Total Share Count - Matribhumi Samachar English\",\"isPartOf\":{\"@id\":\"https:\/\/matribhumisamachar.com\/en\/#website\"},\"datePublished\":\"2026-05-28T10:38:05+00:00\",\"dateModified\":\"2026-05-28T10:38:05+00:00\",\"author\":{\"@id\":\"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/0a61403f4baf9627e92218b53a1e65f1\"},\"description\":\"Zydus Lifesciences revises its ongoing share buyback program, raising the price to \u20b91260 per share while cutting the share count to 87.30 lakh shares. Discover the impact on investors, settlement cycles, and acceptance ratios.\",\"breadcrumb\":{\"@id\":\"https:\/\/matribhumisamachar.com\/en\/2026\/05\/28\/zydus-lifesciences-raises-buyback-price-to-%e2%82%b91260-per-share-trims-total-share-count\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/matribhumisamachar.com\/en\/2026\/05\/28\/zydus-lifesciences-raises-buyback-price-to-%e2%82%b91260-per-share-trims-total-share-count\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/matribhumisamachar.com\/en\/2026\/05\/28\/zydus-lifesciences-raises-buyback-price-to-%e2%82%b91260-per-share-trims-total-share-count\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/matribhumisamachar.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Zydus Lifesciences Raises Buyback Price to \u20b91260 Per Share, Trims Total Share Count\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/matribhumisamachar.com\/en\/#website\",\"url\":\"https:\/\/matribhumisamachar.com\/en\/\",\"name\":\"Matribhumi Samachar English\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/matribhumisamachar.com\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/0a61403f4baf9627e92218b53a1e65f1\",\"name\":\"Saransh Kanaujia\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/45a8b03a1b1bb8255014f5e62f9cfea0eb8a9f7a6a604f9879038df08da23cea?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/45a8b03a1b1bb8255014f5e62f9cfea0eb8a9f7a6a604f9879038df08da23cea?s=96&d=mm&r=g\",\"caption\":\"Saransh Kanaujia\"},\"description\":\"Saransh Kanaujia is currently editor of Matribhumi Samachar Group. He earlier worked with Hindusthan Samachar News Agency. He is also associated with many organizations.\",\"sameAs\":[\"https:\/\/matribhumisamachar.com\/en\"],\"url\":\"https:\/\/matribhumisamachar.com\/en\/author\/matribhumisamachar\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Zydus Lifesciences Raises Buyback Price to \u20b91260 Per Share, Trims Total Share Count - Matribhumi Samachar English","description":"Zydus Lifesciences revises its ongoing share buyback program, raising the price to \u20b91260 per share while cutting the share count to 87.30 lakh shares. Discover the impact on investors, settlement cycles, and acceptance ratios.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/matribhumisamachar.com\/en\/2026\/05\/28\/zydus-lifesciences-raises-buyback-price-to-\u20b91260-per-share-trims-total-share-count\/","og_locale":"en_US","og_type":"article","og_title":"Zydus Lifesciences Raises Buyback Price to \u20b91260 Per Share, Trims Total Share Count - Matribhumi Samachar English","og_description":"Zydus Lifesciences revises its ongoing share buyback program, raising the price to \u20b91260 per share while cutting the share count to 87.30 lakh shares. Discover the impact on investors, settlement cycles, and acceptance ratios.","og_url":"https:\/\/matribhumisamachar.com\/en\/2026\/05\/28\/zydus-lifesciences-raises-buyback-price-to-\u20b91260-per-share-trims-total-share-count\/","og_site_name":"Matribhumi Samachar English","article_published_time":"2026-05-28T10:38:05+00:00","author":"Saransh Kanaujia","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Saransh Kanaujia","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/matribhumisamachar.com\/en\/2026\/05\/28\/zydus-lifesciences-raises-buyback-price-to-%e2%82%b91260-per-share-trims-total-share-count\/","url":"https:\/\/matribhumisamachar.com\/en\/2026\/05\/28\/zydus-lifesciences-raises-buyback-price-to-%e2%82%b91260-per-share-trims-total-share-count\/","name":"Zydus Lifesciences Raises Buyback Price to \u20b91260 Per Share, Trims Total Share Count - Matribhumi Samachar English","isPartOf":{"@id":"https:\/\/matribhumisamachar.com\/en\/#website"},"datePublished":"2026-05-28T10:38:05+00:00","dateModified":"2026-05-28T10:38:05+00:00","author":{"@id":"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/0a61403f4baf9627e92218b53a1e65f1"},"description":"Zydus Lifesciences revises its ongoing share buyback program, raising the price to \u20b91260 per share while cutting the share count to 87.30 lakh shares. Discover the impact on investors, settlement cycles, and acceptance ratios.","breadcrumb":{"@id":"https:\/\/matribhumisamachar.com\/en\/2026\/05\/28\/zydus-lifesciences-raises-buyback-price-to-%e2%82%b91260-per-share-trims-total-share-count\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/matribhumisamachar.com\/en\/2026\/05\/28\/zydus-lifesciences-raises-buyback-price-to-%e2%82%b91260-per-share-trims-total-share-count\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/matribhumisamachar.com\/en\/2026\/05\/28\/zydus-lifesciences-raises-buyback-price-to-%e2%82%b91260-per-share-trims-total-share-count\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/matribhumisamachar.com\/en\/"},{"@type":"ListItem","position":2,"name":"Zydus Lifesciences Raises Buyback Price to \u20b91260 Per Share, Trims Total Share Count"}]},{"@type":"WebSite","@id":"https:\/\/matribhumisamachar.com\/en\/#website","url":"https:\/\/matribhumisamachar.com\/en\/","name":"Matribhumi Samachar English","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/matribhumisamachar.com\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/0a61403f4baf9627e92218b53a1e65f1","name":"Saransh Kanaujia","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/45a8b03a1b1bb8255014f5e62f9cfea0eb8a9f7a6a604f9879038df08da23cea?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/45a8b03a1b1bb8255014f5e62f9cfea0eb8a9f7a6a604f9879038df08da23cea?s=96&d=mm&r=g","caption":"Saransh Kanaujia"},"description":"Saransh Kanaujia is currently editor of Matribhumi Samachar Group. He earlier worked with Hindusthan Samachar News Agency. He is also associated with many organizations.","sameAs":["https:\/\/matribhumisamachar.com\/en"],"url":"https:\/\/matribhumisamachar.com\/en\/author\/matribhumisamachar\/"}]}},"_links":{"self":[{"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/posts\/80430","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/comments?post=80430"}],"version-history":[{"count":1,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/posts\/80430\/revisions"}],"predecessor-version":[{"id":80431,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/posts\/80430\/revisions\/80431"}],"wp:attachment":[{"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/media?parent=80430"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/categories?post=80430"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/tags?post=80430"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}